CHOLANGIOCARCINOMA

This early-stage study tested the safety and highest tolerable dose of an experimental drug called INCB062079 in people with advanced liver cancer and other solid tumors. The trial enrolled 25 participants whose cancers had progressed after standard treatments and was designed to…

This early-stage study tested a personalized cancer treatment that modifies a patient's own immune cells to recognize and attack their specific tumor mutations. The trial enrolled 8 adults with advanced solid tumors (including ovarian, lung, pancreatic, and colorectal cancers) wh…

This early-stage study tested the safety of an experimental treatment called VAXINIA, which is a modified virus designed to infect and kill cancer cells. It was given to 66 adults with advanced solid tumors that had spread and stopped responding to other treatments. The virus was…

This early-stage study aimed to test the safety and find the right dose of a new drug called Felmetatug Vedotin for people with advanced solid tumors. It was for adults with cancers like ovarian, breast, lung, and others that had spread or could not be removed by surgery. The tri…

This study created a registry to collect and store tissue and blood samples from patients undergoing surgery or biopsy for liver or bile duct tumors. The samples are used for future research to better understand these cancers and develop new treatments. The study enrolled 1,000 p…

This study aimed to create a network and database to improve personalized treatment for people with advanced gastrointestinal cancers. It involved collecting and analyzing the genetic profiles of patients' tumors to see if they had specific mutations that could be targeted by exi…

This study aimed to see if simple blood tests could help doctors make better treatment decisions for people with advanced pancreatic, bile duct, or colorectal cancers. Researchers wanted to check if these 'liquid biopsies' could identify the right patients for specific drugs or t…